FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 4, 2026, disclosing their beneficial ownership position in Moderna Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC and Abigail P. Johnson each reported 58,929,948.15 shares of Moderna Inc. common stock beneficially owned.
  • Percent of class: The aggregate position represents 14.8% of Moderna Inc.'s outstanding common stock, according to the filing.
  • Sole voting power (FMR LLC): FMR LLC reported sole voting power over 58,374,817.50 shares, with 0.00 shares subject to shared voting power.
  • Sole dispositive power: FMR LLC reported sole dispositive power over 58,929,948.15 shares; Abigail P. Johnson reported the same sole dispositive power figure.
  • Triggering event date: The date of the event requiring this filing was stated as September 30, 2026.
  • No group membership: The filing indicates shared voting power and shared dispositive power of 0.00 for both reporting persons, and Item 8 is marked "Not Applicable."

FMR LLC and Abigail P. Johnson Disclose Beneficial Ownership Details in Moderna

According to the filing, FMR LLC, organized in Delaware and headquartered at 245 Summer Street, Boston, Massachusetts 02210, submitted Amendment No. 3 to a Schedule 13G covering its beneficial ownership of common stock in Moderna Inc. (CUSIP 60770K107), whose principal offices are listed at 325 Binney Street, Cambridge, MA 02142. The event triggering the amendment occurred on September 30, 2026, and the statement was signed on November 4, 2026.

The filing reports that FMR LLC beneficially owns 58,929,948.15 shares, representing 14.8% of Moderna Inc.'s outstanding common stock. FMR LLC disclosed sole voting power over 58,374,817.50 shares and sole dispositive power over 58,929,948.15 shares. Abigail P. Johnson, identified as a United States individual and a separate reporting person, also reported beneficial ownership of 58,929,948.15 shares with sole dispositive power over that full amount, and 0.00 shares subject to sole or shared voting power. FMR LLC is classified as a parent holding company (type "HC") and Abigail P. Johnson is classified as an individual (type "IN") in the filing.

The filing states that one or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Moderna Inc. common stock, but that no single other person's interest exceeds five percent of the total outstanding common stock. The filing identifies relevant subsidiaries in an attached Exhibit 99. The certification language states the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

FMR LLC and Abigail P. Johnson filed Amendment No. 3 to Schedule 13G reporting combined beneficial ownership of 58,929,948.15 shares, or 14.8%, of Moderna Inc. common stock as of September 30, 2026, with no shared voting or dispositive power reported.